© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
November 28, 2022
Drs Diana Isaacs and Natalie Bellini discuss selecting the right insulin delivery method for patients with diabetes, and the challenges that arise with insulin injectables.
Drs Diana Isaacs and Natalie Bellini provide an overview of the types of insulin delivery systems used in type 1 diabetes (T1D) and type 2 diabetes (T2D), including injections, patches, and inhalable insulin.
Jaynath R. Sridhar, MD, shares insights into managing geographic atrophy in his clinic given that there is no FDA-approved treatment.
David R. Lally, MD, and Jayanth Sridhar, MD, comment on the use of imaging tools to for diagnosis and measuring progression of geographic atrophy.
November 25, 2022
Erin D. Michos, MHS, FACC, FASPC; Pam Taub, MD, FACC, FASPC; Robert Busch, MD; Alison Bailey, MD, FACC; and Jorge Plutzky, MD; share benefits of combination therapy for lipid lowering in ASCVD and hypercholesterolemia.
A panel of experts discusses recommendations for managing statin intolerance in patients with hypercholesterolemia.
November 24, 2022
Expert allergists provide an overview of the phase 3 studies with EDS-FLU for treatment of nasal polyposis.
Naveen Bhandarkar, MD, shares his thoughts on the role of steroid eluting stents in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).
Brett King, MD, PhD, reviews how the drug class has altered the state of chronic skin disease management in this year alone.
Why patience is key following the major FDA decision earlier this year.
Atopic Dermatitis Severity Linked to Incremental Societal Healthcare Costs
Strong Response Maintenance for Plaque Psoriasis Patients Using Tildrakizumab
Clinical Efficacy, Safety of Brolucizumab Similar to Trial Results for nAMD Patients